【领航医药生物科技拟收购Conflux全部股权进军区块链领域】金色财经报道，港股上市公司领航医药生物科技有限公司(00399)宣布签署谅解备忘录，计划收购一家目标公司的全部股权，前提是该目标公司完成对Conflux区块链相关资产的收购。收购对价将通过现金、公司股份或可换股债券支付，具体金额待定。谅解备忘录有效期为12个月，期间卖方不得与第三方就目标公司股权进行谈判。此举旨在帮助领航医药拓展区块链技术业务，实现业务多元化并寻找新的盈利增长点。交易尚需签署正式协议后方可落实。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.